Immune thrombocytopenia
Immune thrombocytopenia is an autoimmune disorder where the body mistakenly destroys its own platelets, leading to a shortage of cells necessary for normal blood clotting.
Overview
Immune thrombocytopenia is characterized by thrombocytopenia, a shortage of platelets. This leads to bleeding under the skin, appearing as small red or purple spots (purpura) or larger bruises (ecchymoses). Significant bleeding episodes, such as nosebleeds or bleeding in the mouth, can occur. In rare, severe cases, intracranial hemorrhage may occur.
Symptoms and Progression
The condition can be diagnosed at any age but is most common in early childhood and late adulthood.
- In children: The reduction in platelets is often sudden but typically resolves within weeks or months. It is sometimes preceded by a minor infection.
- In adults: The development is usually gradual and the condition often persists throughout life.
Causes
Immune thrombocytopenia is an autoimmune condition. The immune system produces antibodies that attack and destroy platelets. Some antibodies also affect the cells in the bone marrow (megakaryocytes) that produce platelets, further reducing their numbers. While the exact genetic cause is unclear, the condition is categorized as:
- Primary Immune Thrombocytopenia: When the destruction of platelets occurs without other underlying conditions.
- Secondary Immune Thrombocytopenia: When it occurs as a feature of other disorders, such as systemic lupus erythematosus, common variable immune deficiency, chronic lymphocytic leukemia, or HIV infection.
Inheritance
While the condition can run in families, the inheritance pattern is unknown. Having a relative with immune thrombocytopenia may increase an individual's risk of developing the disorder.
